All posts by imreal

Oxford Performance Materials Creating Separate Entity for its Orthopedic Implant Business


Oxford Performance Materials, Inc. (OPM; https://oxfordpm.com/), an industry leader in PEKK polymer science and high performance additive manufacturing, is establishing a focused entity for its 3D printed orthopedic business areas following the company’s further expansion into personalized implants. The decision to create a separate orthopedic company will allow greater focus, investment and resources to this high-growth sector of OPM’s business.

SOUTH WINDSOR, Conn., Sept. 19, 2023 /PRNewswire-PRWeb/ — Oxford Performance Materials, Inc. (OPM; https://oxfordpm.com/), an industry leader in PEKK polymer science and high performance additive manufacturing, is establishing a focused entity for its 3D printed orthopedic business areas following the company’s further expansion into personalized implants. The decision to create a separate orthopedic company will allow greater focus, investment and resources to this high-growth sector of OPM’s business.

OPM first began 3D printing cranial and facial implants in 2014, and has delivered patient-matched devices for over 4,500 craniomaxillofacial (CMF) cases to date. The company has six FDA 510(k) clearances.

Until now, surgeons in need of personalized implants for cases in lower & upper extremity, trauma and oncology have had to rely upon 3D printed titanium devices, with recognized drawbacks of stiffness (resulting in stress-shielding and adjacent bone loss), an inability to modify the implant in the O.R., long delivery times, no anti-bacterial properties, poor imaging, and eventual implant corrosion in the body. Like titanium, 3D printed PEKK structures exhibit excellent bone ongrowth, however in contrast, OPM’s 3DP PEKK exceeds titanium in the following ways:

  • A material with bone-like mechanical properties that is fully modifiable in the OR
  • Anti-bacterial properties
  • Corrosion-free
  • Radiolucent
  • Shorter manufacturing times

Analysts tracking the medical device markets consistently report 3D printed implants among the highest growth sectors in orthopedics, and personalized devices are the orthopedic segment experiencing hyper-growth.

“Since our inception in 2000, OPM has been quietly building the most advanced materials and additive manufacturing technology in the orthopedic industry,” said Scott DeFelice, founder & CEO. “Our extension into personalized orthopedic implants began last year, providing devices pro-bono in response to an urgent need in Ukraine. Once specialized surgeons in the U.S. and Europe became aware of the comprehensive solution offered by 3DP PEKK, OPM’s extension from patient-matched CMF to an extended set of personalized devices was a natural step. We have a tiger by the tail here, and the broader decision to separate out our orthopedic offerings will allow greater focus and resources to better serve these customers.”

About Oxford Performance Materials, Inc.

Oxford Performance Materials, Inc. (OPM) was founded in 2000 to develop and commercialize the world’s highest performing thermoplastic, PEKK (poly-ether-ketone-ketone). OPM’s Materials business has developed a range of proprietary, patented technologies for the synthesis and modification of a range of PAEK polymers that are sold under its OXPEKK® brand, including coating technologies for a range of industrial and biomedical applications. OPM is a pioneer in 3D printing. OPM’s OsteoFab® technology is in commercial production in numerous orthopedic implant applications, including cranial, facial, spinal, and sports medicine devices, and OPM’s OXFAB® production parts are designed for highly demanding industrial applications.

Business or Media Inquiries to Oxford Performance Materials:

Bernard Plishtin

Oxford Performance Materials, Inc.

917.494.3649

[email protected]

Media Contact

Vincent DeFelice, Oxford Performance Materials, Inc, 1 4135528304, [email protected], www.oxfordpm.com

SOURCE Oxford Performance Materials, Inc

Tiffany Pankratz-Umbehr, Head of SGS Maine Pointe’s Consumer Goods & Retail Practice, is Recognized as a Recipient of the 2023 Women in Supply Chain Award


“This recognition means a lot not only to me personally, but to all women involved in supply chain management,” said Pankratz-Umbehr. “There are so many prominent women in executive supply chain positions today and that number is growing, as evidenced by the record number of nominations that were received this year. I am very honored to receive this recognition.”

Pankratz-Umbehr’s work in supply chain, her experience and her leadership has been recognized in the past as well, and earlier this year she was named as one of the winners of Supply & Demand Chain Executive’s 2023 Pros to Know award, and also by Food Logistics as a recipient of their Rock Stars of the Supply Chain award program. She is frequently published in industry publications, and is also author of the SGS Maine Pointe white paper, “The Pragmatic Approach to Tackling Disruptions in Consumer Goods and Retail Supply Chains,” which provides insights into how companies can gain stability and flexibility to deal with potential disruptions and turbulence ahead.

“Tiffany has proven to be an invaluable member of our leadership team and a mentor to fellow consultants,” remarked Matthew Lekstutis, CEO of SGS Maine Pointe. “She has swiftly earned the trust of our clients, serving as a reliable advisor, and her insights and leadership have played a crucial role in delivering lasting value.”

The prestigious award honors female supply chain leaders and executives whose accomplishments, mentorship and examples set a foundation for women in all levels of a company’s supply chain network. Recipients will be honored at this year’s Women in Supply Chain Forum, set to take place Nov. 14-15, 2023 in Atlanta.

About SGS Maine Pointe

SGS Maine Pointe is a global supply chain and operations consulting firm that drives compelling economic returns for clients. Our Total Value Optimization (TVO)™ strategy improves EBITDA, cash, growth, and resilience across planning, procurement, logistics, operations, and data analytics.

Working with executives and their teams, we break through functional silos and rapidly transform the plan-buy-make-move supply chain, with an average ROI of 6:1.

Our unique 100% guarantee of engagement fees is based on annualized savings.

About SGS

We are SGS – the world’s leading testing, inspection and certification company. We are recognized as the global benchmark for quality and integrity. Our 98,000 employees operate a network of 2,650 offices and laboratories, working together to enable a better, safer and more interconnected world. SGS has been delivering ESG and sustainability solutions and services to clients for the past 25 years and has been a carbon neutral company for the past seven years.

Media Contact

David Schutzman, SGS Maine Pointe, 1 203 550-8551, [email protected], https://www.mainepointe.com/

SOURCE SGS Maine Pointe

Cayman Chemical Receives CEP for Latanoprost API from EDQM


Cayman Chemical, a world leader in the manufacture of prostaglandins for both research use and as active pharmaceutical ingredients (APIs), has been granted a CEP for its latanoprost API. Cayman Chemical is the first company in the USA to receive a CEP for latanoprost.

ANN ARBOR, Mich., Sept. 19, 2023 /PRNewswire-PRWeb/ — Cayman Chemical, a world leader in the manufacture of prostaglandins for both research use and as active pharmaceutical ingredients (APIs), has been granted a Certification of Suitability to the monographs of the European Pharmacopoeia (CEP) by the European Directorate for the Quality of Medicines and HealthCare (EDQM) for its latanoprost API, effective August 28th, 2023. Cayman Chemical is the first company in the USA to receive a CEP for latanoprost.

A CEP is granted to a manufacturer of an active substance that has demonstrated that the chemical purity and microbiological quality of their substance is adequately controlled by the relevant European Pharmacopoeia monograph and meets European Union (EU) pharmaceutical legislation requirements.

A CEP harmonizes data exchange between regulatory agencies and industry. It confirms that the active substance produced by the manufacturer has met quality standards under Good Manufacturing Practices (GMPs) that make it appropriate and safe for use in medicines. A CEP may be used to simplify the drug application process, as the CEP can be used in the application dossier for marketing authorization, making it easier to receive approval from licensing authorities.

CEPs are recognized by the signatory parties of the Convention on the Elaboration of a European Pharmacopoeia, which includes all European Pharmacopoeia member states and the EU. They are also accepted (some with conditions) by other countries and regulatory authorities. The EDQM has also established a list of authorities and organizations that are allowed access to certification assessment and/or inspection reports from manufacturer sites.

More information on APIs for commercial distribution available from Cayman, including latanoprost, may be found online at http://www.caymanchem.com/apis/overview.

Media Contact

Bryanna Degenhardt, Cayman Chemical, 7349753913, [email protected], www.caymanchem.com

SOURCE Cayman Chemical

Surfacide® Announces Exclusive Distribution of PathTrac®, A Cutting-Edge Clinical Decision Support Software Platform


PathTrac features include:

  • Reservoir Monitoring
  • Bacterial Strains Identification
  • Transmission Mapping
  • Easy to use sampling kits, swabbing takes only minutes
  • Virtual Training
  • Cloud Database and Connectivity

“We are honored to partner with RDB Bioinformatics and be the exclusive provider of PathTrac to hospitals around the country,” said Gunner Lyslol, Founder & CEO of Surfacide. “Optimizing OR hygiene protocols with this important technology prioritizes patient safety and has the ability to significantly reduce the risk of SSI’s and HAI’s, which is costing the healthcare industry more than $6.5 billion each year.”

“At RDB Bioinformatics, we are passionate about our partnership with Surfacide, and having them be the conduit to bringing PathTrac into healthcare facilities. We have an active interest in each other’s separate companies initiatives, while working together to develop shared success in keeping patients safe,” added Dr. Randy Loftus, Co-founder and Chief Medical Officer of RDB Bioinformatics, the owner of PathTrac.

Surfacide is proud to announce its partnership with PathTrac at the OR Manager Conference in Nashville, Tennessee September 18-20 (Booth #926). To learn more about transmission pathways specific to your OR, stop by our booth or get in touch with [email protected] to have a Surfacide consultant set up a baseline assessment of your facility.

PathTrac Video: HERE

Surfacide press kit: HERE

About Surfacide:

Founded in 2010, Surfacide is a UV technology and infection solutions company producing scientifically proven, hospital-grade UV devices. Surfacide’s award-winning Helios® System is the world’s only patented, triple emitter ‘robotic’ UV-C light solution to rapidly reduce bioburden and microorganisms. A trusted partner in infection prevention, Surfacide has been deployed in over 1000 leading hospitals and healthcare facilities worldwide. Surfacide LLC is proud to be American-made and manufactured in Waukesha, WI. Visit the Surfacide website to learn more or contact one of our professional support specialists at (844)-390-3538.

About RDB Bioinformatics:

RDB Bioinformatics is focused on helping patients, hospitals, and the medical community to work together to address HAIs and increasing bacterial resistance. Our primary goals are to address the goals put forth by the Centers for Disease Control including prevention of infections for patients undergoing surgery, prevention of bacterial spread between patients, and improving antibiotic stewardship. Our overarching goal is to maximize patient safety today and for the future, preventing high risk OR bacterial transmission and infection development. https://www.pathtrac.com

Media Contact

Alexandra Skillman, Surfacide, 1 4153426425, [email protected], www.surfacide.com

SOURCE Surfacide

United Breast Cancer Foundation Executive Director, Stephanie Mastroianni, Honored at Twisted Pink Annual Gala


Stephanie Mastroianni’s leadership at UBCF and her unyielding commitment have elevated her as a deserving recipient of the Dace Polk Brown Ambassador Award. Stephanie’s influence and the dedication of the entire UBCF team have provided inspiration and empowerment to countless individuals within the breast cancer community nationwide.

UBCF Executive Director, Stephanie Mastroianni shared, “In over twenty years of working in the breast cancer arena, I have seen first hand what is possible when individuals and organizations focus on doing good in the world, one step at a time. Every day is an opportunity to make a difference, and my commitment remains strong. I am proud of the work my team at UBCF does and I am grateful to work alongside the team at Twisted Pink.”

UBCF’s commitment to serving breast cancer patients and survivors was demonstrated through their sponsorship of 17 metastatic breast cancer patients, along with their respective guests, who attended the gala free of charge. This gesture of kindness and solidarity showcased UBCF’s commitment to standing with breast cancer patients and their families through every step of their journey.

Twisted Pink’s Founder and Executive Director, Caroline Johnson shared, “Stephanie Mastroianni and UBCF truly embody the spirit of our mission. Their support has touched lives and brought awareness to the challenges of breast cancer. We are proud to have them as partners.” Johnson continued, “The synergy between Twisted Pink and United Breast Cancer Foundation has been a beacon of hope for those affected by breast cancer. Together, we have shown that by combining resources and compassion, we can make a tangible difference.”

United Breast Cancer Foundation’s work with Twisted Pink is truly a testament to the power of collaboration and community. The Twisted Pink Annual Gala was a success, thanks to the collaborative efforts of UBCF and the compassionate individuals behind the scenes. The event was a heartwarming celebration of resilience and support, leaving a lasting impression of unity and determination. Everyone present was reminded that together, we can create positive change in the fight against breast cancer.

About United Breast Cancer Foundation:
The United Breast Cancer Foundation is a non-profit founded in 2000 with a mission to make a positive difference in the lives of those impacted by breast cancer. UBCF is committed to funding breast health and wellness services focused on cancer prevention, screening, treatment, overall wellness and beyond. The platinum rated charity offers numerous life-supporting patient and family programs available to women, men, and families nationwide. Tax-deductible contributions may be made towards UBCF’s programs. UBCF accepts contributions through Donor Advised Funds and vehicle and property donations as well. Combined Federal Campaign #77934. http://www.ubcf.org

About Twisted Pink:
Since 2014, Twisted Pink’s efforts have been to provide advocacy and educational programs about metastatic breast cancer. They have been at the forefront of over 3 million dollars supporting metastatic breast cancer research. Twisted Pink’s mission is to provide hope and connectivity to individuals living with metastatic breast cancer and to fund bold breakthroughs in research and awareness of the disease. http://www.twistedpink.org.

Media Contact

Beth Reichart, United Breast Cancer Foundation, 8778224287, [email protected], ubcf.org

Twitter LinkedIn

SOURCE United Breast Cancer Foundation



87% of Workers Say They’ve Had At Least One Toxic Boss: FlexJobs Reports


“Especially for those in a leadership role, we hope these findings underscore how important healthy workplace relationships are to shaping positive employee experiences and supporting strong health and wellness for all workers,” said Toni Frana, Lead Career Expert at FlexJobs.

FlexJobs’ survey, which ran from August 2 to August 17, 2023, explored professionals’ experiences with both toxic managers and toxic co-workers in order to better understand the prevalence of toxic behaviors in the workplace and their impact on employee well-being. Summarized findings below.

State of the Workplace: Toxic Managers

Experience with Toxic Bosses: The majority of people (87%) said they’ve had one (57%) or more than one (30%) toxic bosses or managers in their career, compared to 13% of respondents who said they’ve never had a toxic boss or manager.

When asked which qualities made a boss or manager toxic, workers overwhelmingly listed being a “poor communicator” (43%), acting “dismissively” (41%), and “micromanaging” (40%) as the top three reasons. Other factors specified were:

  • Passive-aggressive behavior (40%)
  • Failure to foster growth (34%)
  • Rude or offensive behavior; used sarcasm and put-downs (33%)
  • Had unreasonable expectations (30%)
  • Didn’t praise or give credit appropriately (26%)
  • Gossiped (22%)
  • Lacked boundaries (21%)
  • Used threats or intimidation (20%)
  • Gaslighting (20%)
  • Discriminatory or sexually inappropriate comments or actions (18%)

Dealing with Toxic Managers: While the majority of workers (43%) said they “quit or left” their job because of a toxic boss or manager, respondents also addressed toxic behavior by:

  • Giving feedback directly to their boss, which was ignored (28%)
  • Giving feedback to HR, which was ignored (21%)
  • “Quiet quitting” their job (12%)
  • Giving feedback directly to their boss, which was applied (11%)
  • Giving feedback to HR, which was applied (8%)

Effects of a Toxic Boss: More than half (51%) of respondents said they’ve experienced “increased anxiety” as a result of having a toxic boss or manager, followed by mental fatigue (44%), and physical symptoms (33%), such as headache, stomach troubles, sleep troubles, or changes in appetite. Job performance also suffered, as specified below.

  • Increased depression (32%)
  • Decline in engagement (30%)
  • Questioning of skill set (30%)
  • Decline in productivity (24%)
  • Decline in performance (24%)
  • Misdirected stress on friends/family (21%)
  • Imposter syndrome (16%)

Notably, “increased anxiety” and “mental fatigue” were the two leading responses across generations, signaling the far-reaching repercussions toxic behaviors from managers can impart across both new and seasoned workforces:

  • Gen Z – Increased anxiety (34%), mental fatigue (25%)        
  • Millennials – Increased anxiety (49%), mental fatigue (41%)
  • Gen X – Increased anxiety (61%), mental fatigue (55%)
  • Boomers – Increased anxiety (52%), mental fatigue (43%)

State of the Workplace: Toxic Co-workers

Experiences with Toxic Co-workers: Similarly to respondents’ experiences with toxic managers, the survey found that the majority of people have also dealt with one or more toxic co-workers:

  • Yes, I have had a toxic co-worker (57%)
  • Yes, I have had more than one toxic co-worker (27%)
  • No (16%)

When asked what made their co-worker(s) toxic, 44% said “excessive complaining and negativity,” as well as “acting unprofessionally” (41%), and “not being a team player” (40%). Other toxic traits cited were:

  • Manipulative or self-serving behavior (35%)
  • Lack of accountability (34%)
  • Passive-aggressive behavior (33%)
  • Gossiped (32%)
  • Focused on blame rather than solutions (32%)
  • Poor communicator (30%)
  • Rude or offensive (30%)
  • Lacked boundaries (29%)
  • Took credit inappropriately (29%)
  • Discriminatory or sexually inappropriate comments or actions (17%)
  • Gaslighting (14%)

Dealing with Toxic Co-workers: Providing feedback directly to the co-worker (26%) or HR (20%), although ignored, were the leading ways people said they’ve handled a toxic colleague. Other methods included: 

  • Quit/left their job (16%)
  • Gave feedback directly to the co-worker, which was applied (15%)
  • Gave feedback to HR, which was applied (14%)
  • Quiet quit (8%)

For more information, please visit https://www.flexjobs.com/blog/post/toxic-managers-coworkers-make-toxic-workplace or contact Shanna Briggs at [email protected].

*FlexJobs created the survey, which was promoted to general audiences and its subscribers/members primarily through social media and newsletters. FlexJobs used a multiple choice and multi-select question format via SurveyMonkey’s online platform. The survey ran from August 2, 2023, to August 17, 2023.

Demographic breakdown of the 8,487 respondents: Gender: women (65%), men (33%) prefer not to identify/self-describe (2%); Generation: Gen Z (12%), millennial/Gen Y (40%), Gen X (31%), baby boomer (16%), silent generation (1%); Education: less than a high school degree (2%), high school degree or equivalent (11%), some college but no degree (21%), associate’s degree (11%), bachelor’s degree (34%), graduate degree (21%); Career level: entry-level (11%), experienced (51%), manager (22%), senior level manager (11%), executive (5%); 43 percent had children 18 or younger living at home with them.

About FlexJobs
FlexJobs is the leading career service specializing in remote, hybrid, and flexible jobs, with over 135 million people having used its resources since 2007. FlexJobs provides the highest-quality database of vetted remote and flexible job listings, from entry-level to executive, startups to public companies, part-time to full-time. To support job seekers in all phases of their career journey, FlexJobs also offers extensive expert advice, webinars, and other resources. In parallel, FlexJobs works with leading companies to recruit quality remote talent and optimize their remote and flexible workplace. A trusted source for data, trends, and insight, FlexJobs has been cited extensively in top national outlets, including CNN, the Wall Street Journal, the New York Times, CNBC, Forbes magazine, and many more. FlexJobs also has partner sites Remote.co and Job-Hunt.org to help round out its content and job search offerings. Follow FlexJobs on LinkedIn, Facebook, Twitter, Instagram, TikTok, and YouTube.

Media Contact

Shanna Briggs, FlexJobs, 866-991-9222, [email protected], www.flexjobs.com

SOURCE FlexJobs



Import Previous Year Data With Just Released 2023 Version of ez1099 Tax Preparation Software


ez1099 software assists in compiling, printing and e-filing these other IRS forms: W2G, 1099-OID, 1097BTC, 1098s (1098, 1098C, 1098E, 1098 T), 1099s (1099A, 1099B, 1099C, 1099CAP, 1099DIV, 1099G, 1099H, 1099INT, 1099LTC, 1099MISC, 1099OID, 1099PATR, 1099Q, 1099R, 1099S, 1099SA), 5498s(5498, 5498ESA, 5498SA), 8935, 3921, 3922, 1096 and 1098 form.

This 1099 tax form printing software can print all recipient copies on plain white paper. Recipient forms can also be printed in PDF format (advanced version purchase required) to be sent via email. ez1099 is compatible with Windows 11, 10 and 8.1 and , 7, 8, and MAC machine installed with Bootcamp program

Cost is only $79 per installation for the basic version of ez1099 Software (per calendar year). Or $139 per installation for the advanced version with bulk printing feature, import feature, PDF file creation and electronic filing capability, ez1099 is affordable for any size business. As always, customers are encouraged to download and try ez1099 without any risk, cost or obligation at https://www.halfpricesoft.com/1099_software.asp

The options featured in the latest version ez1099 software include but are not limited to:

  • ez1099 supports tax forms 1099s, 1098s, 5498s, W2G, 1097BTC, 8935, 3921, 3922 and 1096
  • ez1099 supports white paper printing for recipient copies
  • Quick data import feature
  • Supports compiling and saving form data for later use and modification
  • Supports unlimited accounts and unlimited recipients at no additional charge
  • Go green with optional PDF document converting and e-file (electronic filing) features
  • Fill tax data on pre-printed forms

Halfpricesoft.com welcomes all potential clients to start the no obligation test drive today at
https://www.halfpricesoft.com/1099_software.asp . Please note: TRIAL appears on forms until the license key is purchased.

About halfpricesoft.com
Halfpricesoft.com is a leading provider of small business software,
including online and desktop payroll software, online employee attendance tracking software,
accounting software, in-house business and personal check printing software, W2, software,
1099 software, Accounting software, 1095 form software and ezACH direct deposit software.
Software from halfpricesoft.com is trusted by thousands of customers and will help
Business owners simplify payroll processing and streamline business management.

Media Contact

T. Bernard, halfpricesoft.com, 502-259-0936, [email protected], Halfpricesoft.com

SOURCE halfpricesoft.com

ISPE Unveils First of Its Kind Guidance Document and Launches New Community of Practice on Pharmaceutical Compounding


ISPE Guide: 503B Compounding – Regulatory Basis and Industry Good Practices for Outsourcing Facilities

In response to industry demands and regulatory complexities, ISPE developed this comprehensive guide to serve as an invaluable resource for 503B outsourcing facilities, aiding them in understanding the regulatory requirements outlined in the FD&C Act Section 503B. The Guide combines FDA regulations and recommendations with pharmaceutical industry standards, providing a go-to document for 503B facilities of all sizes. Various aspects of the compounding process are covered, from the importance of CGMPs to establishing a quality system (including qualifying suppliers and vendors), receipt of raw materials/active ingredients, and shipping of finished drug products. The Guide also provides recommendations for facility and equipment design, drawing from aseptic manufacturing practices and scaled to meet the needs of 503B facilities, and presents industry best practices for aseptic manufacturing, emphasizing personnel training and qualification.

The Guide addresses microbiological and analytical testing, including verifying the suitability of compendial methods and validating non-compendial methods. It covers beyond-use dating, offering essential insights into limited stability testing along with stability best practices. A dedicated chapter on preparing for regulatory inspections provides facilities with a valuable resource for this key aspect in ensuring compliance.

ISPE Community of Practice on Pharmaceutical Compounding

Recognizing the pressing need for best practice sharing, training, and guidance for creative problem solving in compounding pharmacies, ISPE launched a new ISPE Community of Practice (CoP) on Pharmaceutical Compounding. This CoP is designed to serve as a dynamic and collaborative community for ISPE members to exchange insights, share best practices, and engage in discussions related to pharmaceutical compounding through the ISPE Engage online platform.

The CoP seeks to foster innovation to improve the practice of pharmaceutical compounding, and to disseminate ideas, knowledge, and best practices through generation of ISPE content, including guidance documents, Pharmaceutical Engineering® Magazine articles, webinars, blog posts, conference presentations, and training materials. The new CoP will provide a venue for industry and regulatory informal interactions to drive practical and effective design and operational practices, while addressing regulatory expectations and providing solid scientific justification for practices accepted by industry and regulators alike.

Individuals interested in being considered for participation on the newly forming Steering Committee to lead the ISPE CoP on Pharmaceutical Compounding are urged to email ISPE at [email protected].

“ISPE is proud to provide critical guidance to the pharmaceutical compounding industry with the release of the “ISPE Guide: 503B Compounding – Regulatory Basis and Industry Good Practices for Outsourcing Facilities” and the launch of the ISPE CoP on Pharmaceutical Compounding,” said Tom Hartman, ISPE President & CEO. “These comprehensive resources signal a transformative step towards fostering collaboration, innovation, and excellence among professionals in this vital sector, and underscore our commitment to advancing knowledge and enhancing compliance within the industry. We believe these initiatives will play a pivotal role in shaping the future of pharmaceutical compounding, ultimately benefitting patients and communities worldwide.”

About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is a global nonprofit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 21,000+ members of ISPE provide solutions to complex pharmaceutical industry challenges through innovation, member and workforce development, and technical, regulatory, and compliance collaborations in more than 120 countries worldwide. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland, USA, and its operations center in Tampa, Florida, USA. For more information, visit ISPE.org.

Media Contact

Brad Ettinger, VP Marketing & Business Development, ISPE, 3013649203, [email protected], www.ispe.org

SOURCE ISPE